VN October 2026

Vetnews | Oktober 2026 32 « BACK TO CONTENTS Case report A 3-year-old male mixed-breed dog weighing 21 kg, of unknown medical history, adopted from a shelter, was presented with suspected retinal detachment and optic disc oedema. The dog showed no improvement after anti-inflammatory therapy. Treatment consisted of systemic corticosteroid therapy using prednisone at a dose of 1 mg/ kg body weight per day, administered orally for two weeks, followed by a gradual taper. According to the owner, the initial clinical concern was night vision impairment. Two complete ophthalmic examinations were performed 10 months apart. Each examination included funduscopy (using a binocular indirect ophthalmoscope [Keeler, UK], a direct ophthalmoscope [Welch Allyn, USA], and a PanOptic ophthalmoscope [Welch Allyn, USA]) and SD-OCT (Topcon 3D OCT-2000, Topcon, Japan). In addition, electroretinography (ERG), with the use of the LKC RETevet system (LKC Technologies, USA), was performed twice, 14 months apart. Ultrasonography (USG) [Vinno G65, Norax] and magnetic resonance imaging (MRI) [GE Optima MR450w 1.5T, GE Medical Systems Polska Sp. z o.o., Warsaw, Poland] were each performed once. The animal owner provided written informed consent for enrollment in the study, procedures and therapy undertaken, and publication of data and images. SDOCT-based retinal morphology and morphometry were compared with data obtained from 11 healthy control mixedbreed dogs of comparable body weight (18–24 kg) and age (2–4 years). Complete blood count and serum biochemistry results were within normal limits. The ophthalmic evaluation included assessments of menace response, dazzle reflex, tracking reflex, and visual placing reflex, as well as an obstacle course test. The obstacle course was conducted first under scotopic and then under photopic conditions. Chromatic pupillary light reflexes were tested using a BPI-50 Precision Illuminator (RetinoGraphics Inc., USA). All the aforementioned reflexes and responses were intact. Schirmer’s Tear Test (Eickemeyer, Germany) and intraocular pressure measurements obtained with a TonoVet rebound tonometer (iCare, Finland) were within normal ranges in both eyes. Slit-lamp biomicroscopy revealed no abnormalities in the anterior segment of either eye. Funduscopic findings Funduscopic examination revealed chorioretinal lesions that differed slightly between the right and left eyes (Fig. 1). In the right eye, two well-demarcated areas of tapetal hyperreflectivity with a pigmented centre were observed. Additionally, two further oval hyperreflective areas were present in the dorsotemporal region. Abnormal retinal pigmentation was also noted within the tapetal fundus. Two well-demarcated areas of depigmentation were present: one at the tapetal-non-tapetal border within the nontapetal fundus of the ventrotemporal region, and the other within the non-tapetal fundus of the ventronasal region. In the left eye, three areas of tapetal hyperreflectivity with a pigmented centre were identified in the dorsotemporal region. As in the right eye, abnormal retinal pigmentation was evident in the tapetal fundus. Furthermore, elevation and blurring of the optic disc margins were observed. During the subsequent funduscopic examination, in the right eye, slight thinning of the retinal blood vessels was observed compared to the previous examination. The chorioretinal lesions’ appearance remained comparable, although progression of abnormal tapetal pigmentation was noted. In the left eye, the funduscopic findings were comparable to those observed during the previous examination. Electroretinography Two ERG examinations were performed using the LKC RETevet system (LKC Technologies, USA) in accordance with the ECVO 5-step protocol. Electroretinography (ERG) was performed twice, at a 14-month interval, as part of the diagnostic evaluation and longitudinal follow-up of suspected retinopathy to assess changes in retinal function over time. Before testing, the pupils were dilated with topical tropicamide (Tropicamidum WZF 1%, Polfa Warszawa S.A., Poland). Anaesthesia was induced using intramuscular dexmedetomidine (Dexdomitor, Orion Pharma, Espoo, Finland) at 2.5 µg/kg and butorphanol (Butomidor, Richter Pharma AG, Wels, Austria) at 0.2 mg/kg, followed by intravenous propofol (PropofolLipuro, B. Braun Melsungen AG, Melsungen, Germany) at 1 mg/kg for induction. After endotracheal intubation, general anaesthesia was maintained with 1% isoflurane (IsoFlo, Zoetis, Louvain-laNeuve, Belgium). Corneal anaesthesia was achieved using 0.5% proxymetacaine hydrochloride (Alcaine 5 mg/mL, Alcon, Warsaw, Poland). The right eye was examined first. In the rod response protocol (white flash, 0.01 cd·s/m², 0.2 Hz, dark adaptation 20 min, no background), both eyes demonstrated reduced amplitudes with normal implicit times. Compared with the initial ERG, the amplitude in the right eye decreased by approximately 70% from baseline, while the left eye showed a reduction of around 20%. A similar amplitude reduction was observed in the cone response protocol (white flash, 3.0 cd·s/m², 2 Hz, light adaptation 10 min, background 30 cd/m²), with approximately 80% reduction in the right eye and 20% in the left eye. These findings indicated bilateral photoreceptor dysfunction, more pronounced in the right eye (Fig. 2). Optical coherence tomography SD-OCT examinations were performed twice-initially on the day of the first visit and again 10 months later. Pupillary dilation was achieved using tropicamide (Tropicamidum WZF 1%, Polfa Figure 1: Fundus photographs of the right (A) and left (B) eyes obtained during the first (1) and second (2) examinations. Article

RkJQdWJsaXNoZXIy OTc5MDU=